MAOA Variants and Genetic Susceptibility to Major Psychiatric Disorders

Molecular Neurobiology

Volumn 53, Issue 7, 2016, Pages 4319-4327

  Liu, Zichao ^a   Huang, Liang ^b   Luo, Xiong jian ^c   Wu, Lichuan ^d   Li, Ming ^c  

^a KUNMING UNIVERSITY   (China)

^b GANNAN MEDICAL UNIVERSITY   (China)

^c KUNMING INSTITUTE OF ZOOLOGY   (China)

^d GUANGXI UNIVERSITY   (China)

Author keywords

Effect size; MAOA; Meta analysis; Psychiatric disorders

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING);

ADULT; ALLELE; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; GENETIC DATABASE; GENETIC SUSCEPTIBILITY; GENETIC VARIATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MAOA GENE; MENTAL DISEASE; PHENOTYPE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS (TOPIC); VARIABLE NUMBER OF TANDEM REPEAT;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MENTAL DISORDERS; META-ANALYSIS AS TOPIC; MINISATELLITE REPEATS; MONOAMINE OXIDASE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84938508285     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9374-0     Document Type: Article

References (76)

1. Craddock N, Jones I (1999) Genetics of bipolar disorder. J Med Genet 36:585–594
2. Jablensky A, Sartorius N, Korten A, Ernberg G, Anker M et al (1987) Incidence worldwide of schizophrenia. Br J Psychiatry 151:408–409
3. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD et al (2009) Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373:234–239
4. Shi Y, Li Z, Xu Q, Wang T, Li T et al (2011) Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. Nat Genet 43:1224–1227
5. Muhleisen TW, Leber M, Schulze TG, Strohmaier J, Degenhardt F et al (2014) Genome-wide association study reveals two new risk loci for bipolar disorder. Nat Commun 5:3339
6. Psychiatric Genomics Consortium Bipolar Disorder Working Group (2011) Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 43:977–983
7. Cichon S, Muhleisen TW, Degenhardt FA, Mattheisen M, Miro X et al (2011) Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet 88:372–381
8. Schizophrenia Working Group of the Psychiatric Genomics C (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 511:421–427
9. Green EK, Grozeva D, Jones I, Jones L, Kirov G et al (2010) The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry 15:1016–1022
10. Williams HJ, Craddock N, Russo G, Hamshere ML, Moskvina V et al (2011) Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. Hum Mol Genet 20:387–391
11. Cross-Disorder Group of the Psychiatric Genomics Consortium (2013) Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381:1371–1379
12. International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM et al (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460:748–752
13. Bergen SE, O'Dushlaine CT, Ripke S, Lee PH, Ruderfer DM et al (2012) Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry 17:880–886
14. Belmaker RH, Agam G (2008) Major depressive disorder. N Engl J Med 358:55–68
15. Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D et al (2006) Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 63:1209–1216
16. Qiu HT, Meng HQ, Song C, Xiu MH, da Chen C et al (2009) Association between monoamine oxidase (MAO)-A gene variants and schizophrenia in a Chinese population. Brain Res 1287:67–73
17. Lin YM, Davamani F, Yang WC, Lai TJ, Sun HS (2008) Association analysis of monoamine oxidase A gene and bipolar affective disorder in Han Chinese. Behav Brain Funct 4:21
18. Schulze TG, Muller DJ, Krauss H, Scherk H, Ohlraun S et al (2000) Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am J Med Genet 96:801–803
19. Zhang J, Chen Y, Zhang K, Yang H, Sun Y et al (2010) A cis-phase interaction study of genetic variants within the MAOA gene in major depressive disorder. Biol Psychiatry 68:795–800
20. Jiang S, Xin R, Lin S, Qian Y, Tang G et al (2001) Linkage studies between attention-deficit hyperactivity disorder and the monoamine oxidase genes. Am J Med Genet 105:783–788
21. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O et al (1999) Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621–624
22. Kunugi H, Ishida S, Kato T, Tatsumi M, Sakai T et al (1999) A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders. Mol Psychiatry 4:393–395
23. Serretti A, Cristina S, Lilli R, Cusin C, Lattuada E et al (2002) Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood disorders. Am J Med Genet 114:361–369
24. Fan JB, Yang MS, Tang JX, He L, Xing YL et al (2004) Family-based association study of the functional monoamine oxidase A gene promoter polymorphism and schizophrenia. Schizophr Res 67:107–109
25. Alvarez S, Mas S, Gasso P, Bernardo M, Parellada E et al (2010) Lack of association between schizophrenia and polymorphisms in dopamine metabolism and transport genes. Fundam Clin Pharmacol 24:741–747
26. Preisig M, Bellivier F, Fenton BT, Baud P, Berney A et al (2000) Association between bipolar disorder and monoamine oxidase A gene polymorphisms: results of a multicenter study. Am J Psychiatry 157:948–955
27. Craddock N, Daniels J, Roberts E, Rees M, McGuffin P et al (1995) No evidence for allelic association between bipolar disorder and monoamine oxidase A gene polymorphisms. Am J Med Genet 60:322–324
28. Furlong RA, Ho L, Rubinsztein JS, Walsh C, Paykel ES et al (1999) Analysis of the monoamine oxidase A (MAOA) gene in bipolar affective disorder by association studies, meta-analyses, and sequencing of the promoter. Am J Med Genet 88:398–406
29. Slopien R, Slopien A, Rozycka A, Warenik-Szymankiewicz A, Lianeri M et al (2012) The c.1460C > T polymorphism of MAO-A is associated with the risk of depression in postmenopausal women. Sci World J 2012:194845
30. Li M, Zhang H, Luo XJ, Gao L, Qi XB et al (2013) Meta-analysis indicates that the European GWAS-identified risk SNP rs1344706 within ZNF804A is not associated with schizophrenia in Han Chinese population. PLoS One 8:e65780
31. Li M, Luo XJ, Rietschel M, Lewis CM, Mattheisen M et al (2014) Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility. Mol Psychiatry 19:452–461
32. Dupont WD, Plummer WD Jr (1990) Power and sample size calculations. A review and computer program. Control Clin Trials 11:116–128
33. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
34. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101
35. Huang SY, Lin MT, Lin WW, Huang CC, Shy MJ et al (2009) Association of monoamine oxidase A (MAOA) polymorphisms and clinical subgroups of major depressive disorders in the Han Chinese population. World J Biol Psychiatry 10:544–551
36. Ma J, Yu SY, Liang S, Ding J, Feng Z et al (2013) Association between MAOA-u VNTR polymorphism and its interaction with stressful life events and major depressive disorder in adolescents. Zhongguo Dang Dai Er Ke Za Zhi 15:563–568
37. Lung FW, Tzeng DS, Huang MF, Lee MB (2011) Association of the MAOA promoter uVNTR polymorphism with suicide attempts in patients with major depressive disorder. BMC Med Genet 12:74
38. Yu YW, Tsai SJ, Hong CJ, Chen TJ, Chen MC et al (2005) Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response. Neuropsychopharmacology 30:1719–1723
39. Melas PA, Wei Y, Wong CC, Sjoholm LK, Aberg E et al (2013) Genetic and epigenetic associations of MAOA and NR3C1 with depression and childhood adversities. Int J Neuropsychopharmacol 16:1513–1528
40. Scholz CJ, Jungwirth S, Danielczyk W, Weber H, Wichart I et al (2014) Investigation of association of serotonin transporter and monoamine oxidase-A genes with Alzheimer's disease and depression in the VITA study cohort: a 90-month longitudinal study. Am J Med Genet B Neuropsychiatr Genet 165B:184–191
41. Rivera M, Gutierrez B, Molina E, Torres-Gonzalez F, Bellon JA et al (2009) High-activity variants of the uMAOA polymorphism increase the risk for depression in a large primary care sample. Am J Med Genet B Neuropsychiatr Genet 150B:395–402
42. Du L, Bakish D, Ravindran A, Hrdina PD (2004) MAO-A gene polymorphisms are associated with major depression and sleep disturbance in males. Neuroreport 15:2097–2101
43. Huang YY, Cate SP, Battistuzzi C, Oquendo MA, Brent D et al (2004) An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology 29:1498–1505
44. Gutierrez B, Arias B, Gasto C, Catalan R, Papiol S et al (2004) Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders. Psychiatr Genet 14:203–208
45. Syagailo YV, Stober G, Grassle M, Reimer E, Knapp M et al (2001) Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disorders. Am J Med Genet 105:168–171
46. Huang SY, Lin MT, Shy MJ, Lin WW, Lin FY et al (2008) Neither single-marker nor haplotype analyses support an association between monoamine oxidase A gene and bipolar disorder. Eur Arch Psychiatry Clin Neurosci 258:350–356
47. Hu MC, Lee SY, Wang TY, Chen SL, Chang YH et al (2013) Association study of DRD2 and MAOA genes with subtyped alcoholism comorbid with bipolar disorder in Han Chinese. Prog Neuropsychopharmacol Biol Psychiatry 40:144–148
48. Sun Y, Zhang J, Yuan Y, Yu X, Shen Y et al (2012) Study of a possible role of the monoamine oxidase A (MAOA) gene in paranoid schizophrenia among a Chinese population. Am J Med Genet B Neuropsychiatr Genet 159B:104–111
49. Iwata Y, Matsumoto H, Minabe Y, Osada N, Nakamura K et al (2003) Early-onset schizophrenia and dopamine-related gene polymorphism. Am J Med Genet B Neuropsychiatr Genet 116B:23–26
50. Camarena B, Fresan A, Aguilar A, Escamilla R, Saracco R et al (2012) Monoamine oxidase a and B gene polymorphisms and negative and positive symptoms in schizophrenia. ISRN Psychiatry 2012:852949
51. Fresan A, Camarena B, Apiquian R, Aguilar A, Urraca N et al (2007) Association study of MAO-A and DRD4 genes in schizophrenic patients with aggressive behavior. Neuropsychobiology 55:171–175
52. Jonsson EG, Norton N, Forslund K, Mattila-Evenden M, Rylander G et al (2003) Association between a promoter variant in the monoamine oxidase A gene and schizophrenia. Schizophr Res 61:31–37
53. Illi A, Mattila KM, Kampman O, Anttila S, Roivas M et al (2003) Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia. J Clin Psychopharmacol 23:429–434
54. Norton N, Kirov G, Zammit S, Jones G, Jones S et al (2002) Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis. Am J Med Genet 114:491–496
55. Fan M, Liu B, Jiang T, Jiang X, Zhao H et al (2010) Meta-analysis of the association between the monoamine oxidase-A gene and mood disorders. Psychiatr Genet 20:1–7
56. Kim SK, Park HJ, Seok H, Jeon HS, Chung JH et al (2014) Association study between monoamine oxidase A (MAOA) gene polymorphisms and schizophrenia: lack of association with schizophrenia and possible association with affective disturbances of schizophrenia. Mol Biol Rep 41:3457–3464
57. Nci-Nhgri Working Group on Replication in Association Studies, Chanock SJ, Manolio T, Boehnke M, Boerwinkle E et al (2007) Replicating genotype-phenotype associations. Nature 447:655–660
58. Eslami Amirabadi MR, Rajezi Esfahani S, Davari-Ashtiani R, Khademi M, Emamalizadeh B et al (2015) Monoamine oxidase a gene polymorphisms and bipolar disorder in Iranian population. Iran Red Crescent Med J 17:e23095
59. Lim LC, Powell J, Sham P, Castle D, Hunt N et al (1995) Evidence for a genetic association between alleles of monoamine oxidase A gene and bipolar affective disorder. Am J Med Genet 60:325–331
60. Muramatsu T, Matsushita S, Kanba S, Higuchi S, Manki H et al (1997) Monoamine oxidase genes polymorphisms and mood disorder. Am J Med Genet 74:494–496
61. Lin S, Jiang S, Wu X, Qian Y, Wang D et al (2000) Association analysis between mood disorder and monoamine oxidase gene. Am J Med Genet 96:12–14
62. Parsian A, Todd RD (1997) Genetic association between monoamine oxidase and manic-depressive illness: comparison of relative risk and haplotype relative risk data. Am J Med Genet 74:475–479
63. Rubinsztein DC, Leggo J, Goodburn S, Walsh C, Jain S et al (1996) Genetic association between monoamine oxidase A microsatellite and RFLP alleles and bipolar affective disorder: analysis and meta-analysis. Hum Mol Genet 5:779–782
64. Kawada Y, Hattori M, Dai XY, Nanko S (1995) Possible association between monoamine oxidase A gene and bipolar affective disorder. Am J Hum Genet 56:335–336
65. Hotamisligil GS, Breakefield XO (1991) Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 49:383–392
66. Tadic A, Rujescu D, Szegedi A, Giegling I, Singer P et al (2003) Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. Am J Med Genet B Neuropsychiatr Genet 117B:1–6
67. Sasaki T, Hattori M, Sakai T, Kato T, Kunugi H et al (1998) The monoamine oxidase-A gene and major psychosis in Japanese subjects. Biol Psychiatry 44:922–924
68. Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 511:421–427
69. Muhleisen TW, Mattheisen M, Strohmaier J, Degenhardt F, Priebe L et al (2012) Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder. Schizophr Res 138:69–73
70. Hennah W, Thomson P, McQuillin A, Bass N, Loukola A et al (2009) DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder. Mol Psychiatry 14:865–873
71. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA (1993) Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262:578–580
72. Cases O, Seif I, Grimsby J, Gaspar P, Chen K et al (1995) Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268:1763–1766
73. Scott AL, Bortolato M, Chen K, Shih JC (2008) Novel monoamine oxidase A knock out mice with human-like spontaneous mutation. Neuroreport 19:739–743
74. Vishnivetskaya GB, Skrinskaya JA, Seif I, Popova NK (2007) Effect of MAO A deficiency on different kinds of aggression and social investigation in mice. Aggress Behav 33:1–6
75. Girard SL, Gauthier J, Noreau A, Xiong L, Zhou S et al (2011) Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet 43:860–863
76. Kirov G (2010) The role of copy number variation in schizophrenia. Expert Rev Neurother 10:25–32